Key Updates
On Holding AG surged 4.55% to $35.37 on May 13th, extending the recovery from the prior session's 5.00% gain and breaking a prolonged decline pattern. This two-day rally of 9.55% represents a technical bounce from oversold conditions, though shares remain down 23.90% year-to-date. The April 25th New York Times article reveals critical strategic developments: On has reached $3.8 billion in annual sales, transitioned to a dual-CEO structure, tripled its workforce since NYSE listing, and expanded R&D from 30 to over 550 employees while opening a South Korean factory for LightSpray technology production. The company faces the defining challenge of scaling mainstream while preserving its performance-focused brand identity.
Current Trend
On Holding remains in a confirmed downtrend with YTD losses of 23.90% and six-month declines of 16.58%, despite the recent two-session recovery. The stock experienced five declines in six trading sessions through May 12th before the current bounce. The recent rally from $32.22 to $35.37 represents a 9.8% recovery but has not yet altered the broader downward trajectory. Technical support appears to have formed near the $32 level, while resistance likely exists around the $36-37 range based on the magnitude of the YTD decline. The current price action suggests a potential short-term oversold bounce rather than a trend reversal, with the stock still trading significantly below year-opening levels.
Investment Thesis
On Holding's investment case centers on sustainable premium positioning in athletic footwear through technology differentiation and controlled brand expansion. The company has demonstrated exceptional revenue growth to $3.8 billion while maintaining its premium market position. The massive R&D expansion to 550+ employees and new South Korean manufacturing capacity for LightSpray technology indicate commitment to innovation-led growth. The dual-CEO structure aims to preserve entrepreneurial agility despite scale. However, the thesis faces execution risk as On navigates the critical inflection point between niche performance brand and mainstream athletic company—a transition that has challenged competitors including Nike and Allbirds. Success depends on avoiding brand dilution while capturing broader market share through celebrity collaborations (Zendaya, Roger Federer) and apparel expansion beyond core running footwear.
Thesis Status
The investment thesis remains intact but faces heightened execution risk. The 23.90% YTD decline reflects market skepticism about On's ability to scale without compromising brand equity—the exact challenge highlighted in the April 25th New York Times article. Positive indicators include the $3.8 billion revenue milestone, substantial R&D investment, and new manufacturing capacity demonstrating operational commitment to growth. The leadership transition to dual CEOs specifically designed to maintain "entrepreneurial speed" addresses scale-related concerns. However, the stock's underperformance suggests investors are pricing in significant risk that On may follow Nike's recent struggles or Allbirds' brand dilution. The expansion into apparel and celebrity partnerships represents both opportunity and risk to core brand identity. The thesis requires monitoring whether innovation investments translate to sustained premium positioning as distribution expands.
Key Drivers
The primary driver is On's strategic navigation of the performance-to-mainstream transition, as detailed in the New York Times article. The company's workforce tripling since NYSE listing and R&D expansion from 30 to 550+ employees signals aggressive investment in innovation capacity. The new South Korean factory for LightSpray technology production represents vertical integration to support proprietary technology scaling. Celebrity collaborations with Zendaya and Roger Federer aim to broaden market appeal while maintaining premium positioning. The dual-CEO leadership structure attempts to preserve agility amid rapid expansion. Market-wide factors include athletic footwear industry consolidation pressures and consumer sensitivity to premium pricing. The competitive landscape features Nike's recent challenges and Allbirds' brand dilution, providing cautionary examples. On's ability to sustain $3.8 billion in sales while expanding product portfolio beyond core running shoes will determine whether the current valuation compression represents opportunity or fundamental repricing.
Technical Analysis
On Holding's chart shows a severe downtrend with 23.90% YTD losses and 16.58% six-month declines, punctuated by a recent two-day 9.55% recovery bounce. The stock found technical support near $32.22 on May 12th after five declines in six sessions, triggering the current rally to $35.37. This bounce exhibits characteristics of an oversold relief rally rather than trend reversal, as the stock remains well below year-opening levels. Key resistance likely exists in the $36-37 range, representing approximately 5% upside from current levels. The one-month gain of 3.45% contrasts sharply with longer-term underperformance, suggesting recent volatility rather than sustained recovery. The five-day decline of 1.91% despite the latest session's 4.55% gain indicates choppy price action. Volume and momentum indicators would be necessary to confirm whether the $32 level represents a durable bottom or temporary support within a broader downtrend. The technical picture suggests cautious positioning until the stock establishes a pattern of higher lows and breaks through resistance levels.
Bull Case
- On achieved $3.8 billion in annual sales with premium positioning intact, demonstrating successful scaling of a performance-focused brand while maintaining pricing power in the athletic footwear market (New York Times)
- R&D expansion from 30 to over 550 employees represents an 18x increase in innovation capacity, positioning On to maintain technological differentiation through proprietary developments like LightSpray running shoe technology (New York Times)
- New South Korean factory for LightSpray production provides vertical integration and manufacturing capacity to scale proprietary technology, reducing dependence on third-party manufacturers and improving margin potential (New York Times)
- Strategic celebrity partnerships with Zendaya and Roger Federer expand brand reach beyond core running community while maintaining premium positioning, unlike competitors who diluted brand equity during expansion (New York Times)
- The 23.90% YTD decline and recent support at $32 may represent valuation compression creating entry opportunity, particularly following the two-day 9.55% technical bounce suggesting oversold conditions have been reached
Bear Case
- On faces the critical challenge of balancing mainstream growth with core performance identity—the same inflection point that has negatively affected competitors Nike and Allbirds, with the stock's 23.90% YTD decline suggesting market skepticism about execution (New York Times)
- Rapid workforce expansion (tripling since NYSE listing) and transition to dual-CEO structure introduce organizational complexity that may compromise the "entrepreneurial speed" the leadership change was designed to preserve (New York Times)
- Product portfolio expansion beyond core running footwear into apparel and lifestyle categories risks brand dilution, particularly as celebrity collaborations broaden market appeal beyond performance-focused customers (New York Times)
- The 16.58% six-month decline and 23.90% YTD loss demonstrate sustained selling pressure that the recent two-day bounce has not reversed, with resistance likely at $36-37 limiting near-term upside potential
- Heavy R&D investment (550+ employees) and new manufacturing infrastructure require sustained revenue growth and margin expansion to justify costs, increasing execution risk if mainstream expansion falters or premium positioning erodes (New York Times)